Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194644 | SCV000247728 | uncertain significance | not specified | 2015-03-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001434490 | SCV001637297 | likely benign | Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847863 | SCV002105245 | likely benign | Hereditary spastic paraplegia | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002327027 | SCV002630950 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004737300 | SCV005344521 | likely benign | KIF1A-related disorder | 2024-09-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |